Frontiers in pharmacologyжурнал

Редколлегия

---

• Нилов Дмитрий Константинович, с 10 марта 2023
• Розенкранц Андрей Александрович, с 1 мая 2019
• Зиновкин Роман Алексеевич, с 22 апреля 2019
• Судьина Галина Федоровна, с 4 февраля 2019
• Соболев Александр Сергеевич, с 25 января 2019

Статьи, опубликованные в журнале

---

• • 2023 Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease
  • Makhaeva Galina F., Kovaleva Nadezhda V., Rudakova Elena V., Boltneva Natalia P., Lushchekina Sofya V., Astakhova Tatiana Yu, Timokhina Elena N., Serebryakova Olga G., Shchepochkin Alexander V., Averkov Maxim A., Utepova Irina A., Demina Nadezhda S., Radchenko Eugene V., Palyulin Vladimir A., Fisenko Vladimir P., Bachurin Sergey O., Chupakhin Oleg N., Charushin Valery N., Richardson Rudy J.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 14, с. 1219980 DOI
• • 2023 Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
  • Rytkin Eric, Kriukova Kseniia, Denisenko Natalia, Ivashchenko Dmitriy, Zastrozhin Michael, Mirzaev Karin, Sychev Dmitry
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 14 DOI
• • 2023 Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
  • Rytkin Eric, Kriukova Kseniia, Denisenko Natalia, Ivashchenko Dmitriy, Zastrozhin Michael, Mirzaev Karin, Sychev Dmitry
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 14 DOI
• 
  • 2022 Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer
  • Xu Jing, Li Jing-quan, Chen Qi-lei, Shestakova Elena A., Misyurin Vsevolod A., Pokrovsky Vadim S., Tchevkina Elena M., Chen Hu-biao, Song Hang, Zhang Jian-ye
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care
  • Huang Z., Chavda V.P., Bezbaruah R., Uversky V.N., Sucharitha P., Patel A.B., Chen Z.S.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13, с. 866827
• 
  • 2022 Cytoplasmic beta and gamma actin isoforms reorganization and regulation in tumor cells in culture and tissue
  • Dugina VB, Shagieva GS, Kopnin PB
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation: Volume II
  • Sokolov Alexey V., Chernyak Boris V., Zinovkin Roman A., Hwang Tsong-Long, Sud’ina Galina F.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13, с. 1-4 DOI
• • 2022 Efficacy of Ficus tikoua Bur. extract in ethylene glycol-induced urolithiasis model in SD rats
  • Bervinova Arina V., Palikov Viktor A., Mikhailov Evgeny S., Palikova Yulia A., Borozdina Natalya A., Kazakov Vitaly A., Rudenko Pavel A., Tukhovskaya Elena A., Dyachenko Igor A., Slashcheva Gulsara A., Goryacheva Natalya A., Sadovnikova Elena S., Kravchenko Irina N., Kalabina Elena A., Shinelev Maksim V., Wu Peng, Murashev Arkady N.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology model
  • Voronova Veronika, Sokolov Victor, Morias Yannick, Boezelman Malin Jonsson, Wågberg Maria, Henricsson Marcus, Hansson Karl, Goltsov Alexey, Peskov Kirill, Sundqvist Monika
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers
  • Alexandrova Antonina, Lomakina Maria
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13, с. 1-21 DOI
• • 2022 Intranasal neuropeptide Y is most effective in some aspects of acute stress compared to melatonin, oxytocin and orexin
  • Zubkov Eugene, Abramova Olga, Zorkina Yana, Ochneva Aleksandra, Ushakova Valeria, Morozova Anna, Gurina Olga, Majouga Alexander, Chekhonin Vladimir
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 Mitochondria-Targeted Antioxidant SkQ1 inhibits Leukotriene Synthesis in Human Neutrophils
  • Sud’ina Galina F., Golenkina Ekaterina A., Prikhodko Anastasia S., Kondratenko Natalia D., Gaponova Tatjana V., Chernyak Boris
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13, с. 1-12 DOI
• 
  • 2022 Raman and fluorescence micro-spectroscopy applied for the monitoring of sunitinib loaded porous silicon nanocontainers in cardiac cells
  • Tolstik Elen, Gongalsky Maxim B., Dierks Johann, Brand Theresa, Pernecker Moritz, Pervushin Nikolay V., Maksutova Daria E., Gonchar Kirill A., Samsonova Jeanne V., Kopeina Gelina, Sivakov Vladimir, Osminkina Liubov A., Lorenz Kristina
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
  • Bondarev Andrey D., Attwood Misty M., Jonsson Jörgen, Chubarev Vladimir N., Tarasov Vadim V., Liu Wen, Schiöth Helgi B.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• 
  • 2022 Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study
  • Akasov R.A., Khaydukov E.V., Andreyuk D.S., Sholina N.V., Sheremeta A.N., Romanov D.V., Kostyuk G.P., Panchenko V.Ya, Kovalchuk M.V.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13, № MAR, с. 755745 DOI
• • 2022 Synthesis, Screening and Characterization of Novel Potent Arp2/3 Inhibitory Compounds Analogous to CK-666
  • Fokin Artem I., Chuprov-Netochin Roman N., Malyshev Alexander S., Romero Stéphane, Semenova Marina N., Konyushkin Leonid D., Leonov Sergey V., Semenov Victor V., Gautreau Alexis M.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 13 DOI
• • 2022 Toxicological properties of 7-methylguanine, and preliminary data on its anticancer activity
  • Kirsanov K., Fetisov T., Antoshina E., Trukhanova L., Gor’kova T., Vlasova O., Khitrovo I., Lesovaya E., Kulbachevskaya N., Shcherbakova T., Belitsky G., Yakubovskaya M., Švedas V., Nilov D.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland) DOI
• • 2021 9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells
  • Poloznikov A., Nikulin S., Bolotina L., Kachmazov A., Raigorodskaya M., Kudryavtseva A., Bakhtogarimov I., Rodin S., Gaisina I., Topchiy M., Asachenko A., Novosad V., Tonevitsky A., Alekseev B.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), № 12 DOI
• 
  • 2021 Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
  • Chernyak Boris V., Sokolov Alexey V., Hwang Tsong-Long, Zinovkin Roman A., Sud’ina Galina F.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 12, с. 1-3 DOI
• • 2021 From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds
  • Skvortsov D.A., Kalinina M.A., Zhirkina I.V., Vasilyeva L.A., Ivanenkov Y.A., Sergiev P.V., Dontsova O.A.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 12 DOI
• 
  • 2021 Gene Expression Pattern of Peyer’s Patch Lymphocytes Exposed to Kagocel Suggests Pattern-Recognition Receptors Mediate Its Action
  • Andreev-Andrievskiy Alexander A., Zinovkin Roman A., Mashkin Mikhail A., Frolova Olga Yu, Kazaishvili Yuriy G., Scherbakova Victoria S., Rudoy Boris A., Nesterenko Vladimir G.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 12, с. 1-12 DOI
• 
  • 2021 Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming
  • Golenkina Ekaterina A., Galkina Svetlana I., Pletjushkina Olga, Chernyak Boris, Gaponova Tatjana V., Romanova Yulia M., Sud’ina Galina F.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 12, с. 1-10 DOI
• • 2021 HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
  • Poloznikov Andrey A., Nersisyan Stepan A., Hushpulian Dmitry M., Kazakov Eliot H., Tonevitsky Alexander G., Kazakov Sergey V., Vechorko Valery I., Nikulin Sergey V., Makarova Julia A., Gazaryan Irina G.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 11 DOI
• 
  • 2021 Inhibition of Neutrophil Secretion Upon Adhesion as a Basis for the Anti-Inflammatory Effect of the Tricyclic Antidepressant Imipramine
  • Galkina Svetlana I., Golenkina Ekaterina A., Fedorova Natalia V., Ksenofontov Alexander L., Serebryakova Marina V., Arifulin Evgenii A., Stadnichuk Vladimir I., Baratova Ludmila A., Sud’ina Galina F.
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 12, с. 1-13 DOI
• 
  • 2021 Mitochondria are potential targets for the development of new drugs against neutrophilic inflammation in severe pneumonia including COVID-19
  • Vorobjeva NV, Sud'ina GF, Chernyak BV
  • в журнале Frontiers in pharmacology, издательство Frontiers Media] ([Lausanne, Switzerland), том 12, с. 1-4 DOI